anonymous
Guest
anonymous
Guest
It's been awhile since HQ has given us a heads up.... Last time they did there were other drugs in the mix.... Once weekly dpp4... Dropped... Osteoporosis ... Dropped.... Generic insulin which kinda had the message that sales may not actively promote it when it hits....
What the hell is left for us to sell in 2017 besides Januvia (which will be interesting if managed care plans pick up nesina on price) Sleep( which is way off the mark nationally .. And asthma.. I have no idea what that pulls in anymore
What the hell is left for us to sell in 2017 besides Januvia (which will be interesting if managed care plans pick up nesina on price) Sleep( which is way off the mark nationally .. And asthma.. I have no idea what that pulls in anymore